---
figid: PMC3075579__10.1177_0022034510381264-fig4
figtitle: The PI3K pathway in TLR-signaling
organisms:
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Leishmania major
- Homo sapiens
- Saccharomyces cerevisiae
- Porphyromonas gingivalis
- Measles morbillivirus
organisms_ner:
- Drosophila melanogaster
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC3075579
filename: 10.1177_0022034510381264-fig4.jpg
figlink: /pmc/articles/PMC3075579/figure/fig4-0022034510381264/
number: F4
caption: The role of the PI3K pathway in TLR-signaling. TLR stimulation activates
  the PI3K/Akt signaling pathway. Upon TLR activation, PI3K is recruited and converts
  phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate
  (PIP3), which allows for the recruitment of signaling molecules that possess a plekstrin
  homology domain, i.e., Akt. Activation of Akt by PDK1 (Thr308) and mTORC2 (Ser473)
  results in its full activation. Activated Akt can phosphorylate GSK3-α (Ser21) or
  GSK3-β (Ser9), and this site-specific phosphorylation results in the inactivation
  of GSK3. Inactivation of GSK3 promotes increased nuclear levels of CREB (Ser133)
  that displace NF-κB p65 (Ser273) from the co-activator of transcription CBP. The
  enhanced transcriptional activity of CREB and reduced transcriptional activity of
  NF-κB p65 result in increased IL-10 production while concurrently suppressing the
  levels of pro-inflammatory cytokines. Alternately, activated Akt can inhibit GSK3
  activity indirectly through mTORC1. Active Akt inhibits the TCS2/1 complex. Once
  the TSC2/1 complex is inhibited, mTORC1 is activated, which, in turn, phosphorylates
  and activates both S6K isoforms, p70 and p85 S6K. S6K has been shown to affect the
  phosphorylation of GSK3, but it is unknown if the phosphorylation of GSK3 is due
  to a direct or indirect effect of S6K activity. Inhibition of mTORC1 with rapamycin
  attenuates phosphorylation of GSK3 and STAT3, augments NF-κB activation, and increases
  pro-inflammatory cytokine production (TNF and IL-12).
papertitle: TLR-signaling Networks.
reftext: J. Brown, et al. J Dent Res. 2011 Apr;90(4):417-427.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9441711
figid_alias: PMC3075579__F4
figtype: Figure
redirect_from: /figures/PMC3075579__F4
ndex: 561b2e22-deff-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3075579__10.1177_0022034510381264-fig4.html
  '@type': Dataset
  description: The role of the PI3K pathway in TLR-signaling. TLR stimulation activates
    the PI3K/Akt signaling pathway. Upon TLR activation, PI3K is recruited and converts
    phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate
    (PIP3), which allows for the recruitment of signaling molecules that possess a
    plekstrin homology domain, i.e., Akt. Activation of Akt by PDK1 (Thr308) and mTORC2
    (Ser473) results in its full activation. Activated Akt can phosphorylate GSK3-α
    (Ser21) or GSK3-β (Ser9), and this site-specific phosphorylation results in the
    inactivation of GSK3. Inactivation of GSK3 promotes increased nuclear levels of
    CREB (Ser133) that displace NF-κB p65 (Ser273) from the co-activator of transcription
    CBP. The enhanced transcriptional activity of CREB and reduced transcriptional
    activity of NF-κB p65 result in increased IL-10 production while concurrently
    suppressing the levels of pro-inflammatory cytokines. Alternately, activated Akt
    can inhibit GSK3 activity indirectly through mTORC1. Active Akt inhibits the TCS2/1
    complex. Once the TSC2/1 complex is inhibited, mTORC1 is activated, which, in
    turn, phosphorylates and activates both S6K isoforms, p70 and p85 S6K. S6K has
    been shown to affect the phosphorylation of GSK3, but it is unknown if the phosphorylation
    of GSK3 is due to a direct or indirect effect of S6K activity. Inhibition of mTORC1
    with rapamycin attenuates phosphorylation of GSK3 and STAT3, augments NF-κB activation,
    and increases pro-inflammatory cytokine production (TNF and IL-12).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - mal
  - bs
  - Mrtf
  - TRAM
  - Myd88
  - Pdk1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - Akt
  - tre
  - Gr5a
  - Treh
  - Tre1
  - Traf6
  - sgg
  - Rheb
  - Tak1
  - Dif
  - dl
  - Rel
  - CrebB
  - CrebA
  - displaced
  - egr
  - CBP
  - nej
  - eIF4E1
  - wash
  - Mal
  - Pnma1
  - Rnf138
  - Pik3cg
  - Gprasp1
  - Akt1
  - Map3k7
  - Nfkb1
  - Creb1
  - Il12b
  - Tnf
  - Crebbp
  - Pag1
  - Irf3
  - Syt1
  - Il1b
  - Il10
  - MAL
  - MRTFA
  - TIRAP
  - PNMA1
  - GSTZ1
  - TRAM1
  - TICAM2
  - TMED7-TICAM2
  - TRIM69
  - TICAM1
  - MYD88
  - PDK1
  - PDPK1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - IRAK1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - TRE-TTC3-1
  - TREH
  - TRAF6
  - GSK3A
  - GSK3B
  - RHEB
  - RHEBP1
  - MAP3K7
  - NR2C2
  - NFKB1
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - IL12A
  - IL12B
  - TNF
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - IRF3
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - IL1B
  - IL10
  - Tirap
  - Mrtfa
  - Tmed7
  - Ticam2
  - Trim69
  - Ticam1
  - Pdpk1
  - Pik3r1
  - Irak1
  - Gsk3b
  - Nr2c2
  - ba
  - Cytip
  - Rela
  - Gorasp1
  - tirap
  - malb
  - tram1
  - ticam1
  - myd88
  - pdk1
  - ptenb
  - traf6
  - gsk3ba
  - gsk3ab
  - rheb
  - rhebl1
  - tnfa
  - tnfb
  - irf3
  - rela
  - il1b
  - il10
  - Rapamycin
---
